Is Citizens Financial Group, Inc. (Rhode Island) overvalued or undervalued?
As of July 17, 2025, Citizens Financial Group, Inc. is considered very attractive due to its undervalued P/E ratio of 15, strong performance with a year-to-date return of 22.58%, and a high dividend yield of 331.50%, despite its Price to Book Value of 0.96 and PEG Ratio of 1.14.
As of 17 July 2025, the valuation grade for Citizens Financial Group, Inc. has moved from fair to very attractive. The company appears to be undervalued, particularly when considering its P/E ratio of 15, which is lower than peers such as Huntington Bancshares, Inc. at 12.37 and Regions Financial Corp. at 12.07. Additionally, the Price to Book Value stands at 0.96, and the PEG Ratio is 1.14, indicating potential for growth relative to its valuation.In terms of performance, Citizens Financial Group has outperformed the S&P 500 across various time frames, with a year-to-date return of 22.58% compared to the S&P 500's 12.22%. This trend reinforces the attractiveness of the stock, especially given its strong dividend yield of 331.50% and ROCE of 8.82%, which further support the argument for its undervaluation in the current market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
